Hofseth Biocare A (HBC.OL) Stock Price

Hofseth Biocare ASA develops, markets, and sells biomarine ingredients including Salmon protein hydrolysate (ProGo), Fresh salmon oil (OmeGo), Calcium bone powder (CalGo), and CollaGo collagen peptide powder. The company targets sports nutrition, health, and beauty markets with products designed for endurance recovery, omega fatty acid supplementation, and skin/hair/nail enhancement. ProGo is sold as a protein powder for sports and recovery, OmeGo provides natural omega fatty acids for health, CalGo serves as a marine calcium source, and CollaGo supports beauty applications. Hofseth Biocare operates through its headquarters in Alesund and branches in Oslo, Chicago, Mumbai, Tokyo, and Menlo Park, California, serving customers in these global locations. The company generates revenue through direct sales of its four core products to health and wellness brands, sports nutrition companies, and beauty product manufacturers. ProGo is marketed to sports and recovery powder producers, OmeGo to health supplement brands requiring omega fatty acids, CalGo to dietary calcium suppliers, and CollaGo to beauty product developers. Hofseth Biocare's business model focuses on supplying specialized marine-derived ingredients to established brands rather than selling directly to end consumers. Hofseth Biocare ASA's product portfolio includes ProGo, OmeGo, CalGo, and CollaGo, each targeting specific market segments: sports nutrition, health supplements, dietary calcium, and beauty products. The company's sales strategy involves partnerships with manufacturers who integrate these ingredients into their final consumer products. This approach allows Hofseth Biocare to maintain a B2B business model without direct consumer engagement, leveraging its marine ingredient expertise to serve multiple industries through its branded product lines.